Latest Drugs, Latest Approval in Non-sulfonylureas

What are Non-sulfonylureas?

Biguanides are classed as non-sulfonylureas. Metformin is the only available biguanide for diabetes treatment. It inhibits the amount of glucose produced by the liver, increases the insulin-receptor binding and stimulates tissue uptake of glucose. Metformin does not stimulate the pancreas to make or release more insulin so doesn't cause hypoglycemia.

Metformin is used to treat Type 2 diabetes.

Name Updated
Metformin (eqv-glumetza) (Metformin [ met-for-min ]) 16-Aug-2023
Metformin (eqv-glucophage xr) (Metformin [ met-for-min ]) 16-Aug-2023
Metformin (eqv-fortamet) (Metformin [ met-for-min ]) 16-Aug-2023
Metformin (Metformin [ met-for-min ]) 11-Aug-2023
Riomet (Metformin [ met-for-min ]) 14-Jul-2023
Glumetza (Metformin [ met-for-min ]) 13-Jul-2023
Glucophage xr (Metformin [ met-for-min ]) 13-Jul-2023
Fortamet (Metformin [ met-for-min ]) 13-Jul-2023
Glucophage (Metformin [ met-for-min ]) 10-Jul-2023